Next Generation Sequencing Market Size, Top Share And Report Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Next Generation Sequencing Market Size Analysis

Global Next Generation Sequencing Market Introduction
By Type of Sequencing
1. Introduction
  1. Type of Sequencing By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing & Resequencing
  1. By Value
  2. DNA-based
    1. DNA-based By Value
  3. RNA-based
    1. RNA-based By Value
4. Whole Exome Sequencing
  1. By Value
5. RNA Sequencing
  1. By Value
6. CHIP Sequencing
  1. By Value
7. De Novo Sequencing
  1. By Value
8. Methyl Sequencing
  1. By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Services
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinical Laboratories
  1. By Value
3. Academics and Research Institutions
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Drug Discovery and Personalized Medicine
  1. By Value
3. Genetic Screening
  1. By Value
4. Agriculture and Animal Research
  1. By Value
5. Biomarkers and cancer
  1. By Value
6. Oncology
  1. By Value
  2. Diagnostics and Screening
    1. Diagnostics and Screening By Value
    2. Oncology Screening
      1. Oncology Screening By Value
    3. Companion Diagnostics
      1. Companion Diagnostics By Value
    4. Other Diagnostics
      1. Other Diagnostics By Value
  3. Research Studies
    1. Research Studies By Value
7. Clinical Investigation
  1. By Value
  2. Infectious Diseases
    1. Infectious Diseases By Value
  3. Inherited Diseases
    1. Inherited Diseases By Value
  4. Idiopathic Diseases
    1. Idiopathic Diseases By Value
  5. Non-Communicable/Other Diseases
    1. Non-Communicable/Other Diseases By Value
8. Reproductive Health
  1. By Value
  2. NIPT
    1. NIPT By Value
    2. Aneuploidy
      1. Aneuploidy By Value
    3. Microdeletions
      1. Microdeletions By Value
  3. PGT
    1. PGT By Value
  4. Newborn Genetic Screening
    1. Newborn Genetic Screening By Value
  5. Single Gene Analysis
    1. Single Gene Analysis By Value
9. HLA Typing/Immune System Monitoring
  1. By Value
10. Metagenomics, Epidemiology & Drug Development
  1. By Value
11. Agrigenomics & Forensics
  1. By Value
12. Consumer Genomics
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Sequencing by Ligation
  1. By Value
5. Pyrosequencing
  1. By Value
6. Single Molecule Real Time Sequencing
  1. By Value
7. Other Technologies
  1. By Value

North America Market Analysis

Introduction
By Type of Sequencing
1. Introduction
  1. Type of Sequencing By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing & Resequencing
  1. By Value
  2. DNA-based
    1. DNA-based By Value
  3. RNA-based
    1. RNA-based By Value
4. Whole Exome Sequencing
  1. By Value
5. RNA Sequencing
  1. By Value
6. CHIP Sequencing
  1. By Value
7. De Novo Sequencing
  1. By Value
8. Methyl Sequencing
  1. By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Services
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinical Laboratories
  1. By Value
3. Academics and Research Institutions
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Drug Discovery and Personalized Medicine
  1. By Value
3. Genetic Screening
  1. By Value
4. Agriculture and Animal Research
  1. By Value
5. Biomarkers and cancer
  1. By Value
6. Oncology
  1. By Value
  2. Diagnostics and Screening
    1. Diagnostics and Screening By Value
    2. Oncology Screening
      1. Oncology Screening By Value
    3. Companion Diagnostics
      1. Companion Diagnostics By Value
    4. Other Diagnostics
      1. Other Diagnostics By Value
  3. Research Studies
    1. Research Studies By Value
7. Clinical Investigation
  1. By Value
  2. Infectious Diseases
    1. Infectious Diseases By Value
  3. Inherited Diseases
    1. Inherited Diseases By Value
  4. Idiopathic Diseases
    1. Idiopathic Diseases By Value
  5. Non-Communicable/Other Diseases
    1. Non-Communicable/Other Diseases By Value
8. Reproductive Health
  1. By Value
  2. NIPT
    1. NIPT By Value
    2. Aneuploidy
      1. Aneuploidy By Value
    3. Microdeletions
      1. Microdeletions By Value
  3. PGT
    1. PGT By Value
  4. Newborn Genetic Screening
    1. Newborn Genetic Screening By Value
  5. Single Gene Analysis
    1. Single Gene Analysis By Value
9. HLA Typing/Immune System Monitoring
  1. By Value
10. Metagenomics, Epidemiology & Drug Development
  1. By Value
11. Agrigenomics & Forensics
  1. By Value
12. Consumer Genomics
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Sequencing by Ligation
  1. By Value
5. Pyrosequencing
  1. By Value
6. Single Molecule Real Time Sequencing
  1. By Value
7. Other Technologies
  1. By Value
U.S.
1. By Type of Sequencing
  1. Introduction
    1. Type of Sequencing By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing & Resequencing
    1. By Value
    2. DNA-based
      1. DNA-based By Value
    3. RNA-based
      1. RNA-based By Value
  4. Whole Exome Sequencing
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. CHIP Sequencing
    1. By Value
  7. De Novo Sequencing
    1. By Value
  8. Methyl Sequencing
    1. By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Services
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinical Laboratories
    1. By Value
  3. Academics and Research Institutions
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Drug Discovery and Personalized Medicine
    1. By Value
  3. Genetic Screening
    1. By Value
  4. Agriculture and Animal Research
    1. By Value
  5. Biomarkers and cancer
    1. By Value
  6. Oncology
    1. By Value
    2. Diagnostics and Screening
      1. Diagnostics and Screening By Value
      2. Oncology Screening
        
        Oncology Screening By Value
      3. Companion Diagnostics
        
        Companion Diagnostics By Value
      4. Other Diagnostics
        
        Other Diagnostics By Value
    3. Research Studies
      1. Research Studies By Value
  7. Clinical Investigation
    1. By Value
    2. Infectious Diseases
      1. Infectious Diseases By Value
    3. Inherited Diseases
      1. Inherited Diseases By Value
    4. Idiopathic Diseases
      1. Idiopathic Diseases By Value
    5. Non-Communicable/Other Diseases
      1. Non-Communicable/Other Diseases By Value
  8. Reproductive Health
    1. By Value
    2. NIPT
      1. NIPT By Value
      2. Aneuploidy
        
        Aneuploidy By Value
      3. Microdeletions
        
        Microdeletions By Value
    3. PGT
      1. PGT By Value
    4. Newborn Genetic Screening
      1. Newborn Genetic Screening By Value
    5. Single Gene Analysis
      1. Single Gene Analysis By Value
  9. HLA Typing/Immune System Monitoring
    1. By Value
  10. Metagenomics, Epidemiology & Drug Development
    1. By Value
  11. Agrigenomics & Forensics
    1. By Value
  12. Consumer Genomics
    1. By Value
5. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Sequencing by Ligation
    1. By Value
  5. Pyrosequencing
    1. By Value
  6. Single Molecule Real Time Sequencing
    1. By Value
  7. Other Technologies
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type of Sequencing
1. Introduction
  1. Type of Sequencing By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing & Resequencing
  1. By Value
  2. DNA-based
    1. DNA-based By Value
  3. RNA-based
    1. RNA-based By Value
4. Whole Exome Sequencing
  1. By Value
5. RNA Sequencing
  1. By Value
6. CHIP Sequencing
  1. By Value
7. De Novo Sequencing
  1. By Value
8. Methyl Sequencing
  1. By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Services
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinical Laboratories
  1. By Value
3. Academics and Research Institutions
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Drug Discovery and Personalized Medicine
  1. By Value
3. Genetic Screening
  1. By Value
4. Agriculture and Animal Research
  1. By Value
5. Biomarkers and cancer
  1. By Value
6. Oncology
  1. By Value
  2. Diagnostics and Screening
    1. Diagnostics and Screening By Value
    2. Oncology Screening
      1. Oncology Screening By Value
    3. Companion Diagnostics
      1. Companion Diagnostics By Value
    4. Other Diagnostics
      1. Other Diagnostics By Value
  3. Research Studies
    1. Research Studies By Value
7. Clinical Investigation
  1. By Value
  2. Infectious Diseases
    1. Infectious Diseases By Value
  3. Inherited Diseases
    1. Inherited Diseases By Value
  4. Idiopathic Diseases
    1. Idiopathic Diseases By Value
  5. Non-Communicable/Other Diseases
    1. Non-Communicable/Other Diseases By Value
8. Reproductive Health
  1. By Value
  2. NIPT
    1. NIPT By Value
    2. Aneuploidy
      1. Aneuploidy By Value
    3. Microdeletions
      1. Microdeletions By Value
  3. PGT
    1. PGT By Value
  4. Newborn Genetic Screening
    1. Newborn Genetic Screening By Value
  5. Single Gene Analysis
    1. Single Gene Analysis By Value
9. HLA Typing/Immune System Monitoring
  1. By Value
10. Metagenomics, Epidemiology & Drug Development
  1. By Value
11. Agrigenomics & Forensics
  1. By Value
12. Consumer Genomics
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Sequencing by Ligation
  1. By Value
5. Pyrosequencing
  1. By Value
6. Single Molecule Real Time Sequencing
  1. By Value
7. Other Technologies
  1. By Value
U.K.
1. By Type of Sequencing
  1. Introduction
    1. Type of Sequencing By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing & Resequencing
    1. By Value
    2. DNA-based
      1. DNA-based By Value
    3. RNA-based
      1. RNA-based By Value
  4. Whole Exome Sequencing
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. CHIP Sequencing
    1. By Value
  7. De Novo Sequencing
    1. By Value
  8. Methyl Sequencing
    1. By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Services
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinical Laboratories
    1. By Value
  3. Academics and Research Institutions
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Drug Discovery and Personalized Medicine
    1. By Value
  3. Genetic Screening
    1. By Value
  4. Agriculture and Animal Research
    1. By Value
  5. Biomarkers and cancer
    1. By Value
  6. Oncology
    1. By Value
    2. Diagnostics and Screening
      1. Diagnostics and Screening By Value
      2. Oncology Screening
        
        Oncology Screening By Value
      3. Companion Diagnostics
        
        Companion Diagnostics By Value
      4. Other Diagnostics
        
        Other Diagnostics By Value
    3. Research Studies
      1. Research Studies By Value
  7. Clinical Investigation
    1. By Value
    2. Infectious Diseases
      1. Infectious Diseases By Value
    3. Inherited Diseases
      1. Inherited Diseases By Value
    4. Idiopathic Diseases
      1. Idiopathic Diseases By Value
    5. Non-Communicable/Other Diseases
      1. Non-Communicable/Other Diseases By Value
  8. Reproductive Health
    1. By Value
    2. NIPT
      1. NIPT By Value
      2. Aneuploidy
        
        Aneuploidy By Value
      3. Microdeletions
        
        Microdeletions By Value
    3. PGT
      1. PGT By Value
    4. Newborn Genetic Screening
      1. Newborn Genetic Screening By Value
    5. Single Gene Analysis
      1. Single Gene Analysis By Value
  9. HLA Typing/Immune System Monitoring
    1. By Value
  10. Metagenomics, Epidemiology & Drug Development
    1. By Value
  11. Agrigenomics & Forensics
    1. By Value
  12. Consumer Genomics
    1. By Value
5. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Sequencing by Ligation
    1. By Value
  5. Pyrosequencing
    1. By Value
  6. Single Molecule Real Time Sequencing
    1. By Value
  7. Other Technologies
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type of Sequencing
1. Introduction
  1. Type of Sequencing By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing & Resequencing
  1. By Value
  2. DNA-based
    1. DNA-based By Value
  3. RNA-based
    1. RNA-based By Value
4. Whole Exome Sequencing
  1. By Value
5. RNA Sequencing
  1. By Value
6. CHIP Sequencing
  1. By Value
7. De Novo Sequencing
  1. By Value
8. Methyl Sequencing
  1. By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Services
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinical Laboratories
  1. By Value
3. Academics and Research Institutions
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Drug Discovery and Personalized Medicine
  1. By Value
3. Genetic Screening
  1. By Value
4. Agriculture and Animal Research
  1. By Value
5. Biomarkers and cancer
  1. By Value
6. Oncology
  1. By Value
  2. Diagnostics and Screening
    1. Diagnostics and Screening By Value
    2. Oncology Screening
      1. Oncology Screening By Value
    3. Companion Diagnostics
      1. Companion Diagnostics By Value
    4. Other Diagnostics
      1. Other Diagnostics By Value
  3. Research Studies
    1. Research Studies By Value
7. Clinical Investigation
  1. By Value
  2. Infectious Diseases
    1. Infectious Diseases By Value
  3. Inherited Diseases
    1. Inherited Diseases By Value
  4. Idiopathic Diseases
    1. Idiopathic Diseases By Value
  5. Non-Communicable/Other Diseases
    1. Non-Communicable/Other Diseases By Value
8. Reproductive Health
  1. By Value
  2. NIPT
    1. NIPT By Value
    2. Aneuploidy
      1. Aneuploidy By Value
    3. Microdeletions
      1. Microdeletions By Value
  3. PGT
    1. PGT By Value
  4. Newborn Genetic Screening
    1. Newborn Genetic Screening By Value
  5. Single Gene Analysis
    1. Single Gene Analysis By Value
9. HLA Typing/Immune System Monitoring
  1. By Value
10. Metagenomics, Epidemiology & Drug Development
  1. By Value
11. Agrigenomics & Forensics
  1. By Value
12. Consumer Genomics
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Sequencing by Ligation
  1. By Value
5. Pyrosequencing
  1. By Value
6. Single Molecule Real Time Sequencing
  1. By Value
7. Other Technologies
  1. By Value
China
1. By Type of Sequencing
  1. Introduction
    1. Type of Sequencing By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing & Resequencing
    1. By Value
    2. DNA-based
      1. DNA-based By Value
    3. RNA-based
      1. RNA-based By Value
  4. Whole Exome Sequencing
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. CHIP Sequencing
    1. By Value
  7. De Novo Sequencing
    1. By Value
  8. Methyl Sequencing
    1. By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Services
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinical Laboratories
    1. By Value
  3. Academics and Research Institutions
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Drug Discovery and Personalized Medicine
    1. By Value
  3. Genetic Screening
    1. By Value
  4. Agriculture and Animal Research
    1. By Value
  5. Biomarkers and cancer
    1. By Value
  6. Oncology
    1. By Value
    2. Diagnostics and Screening
      1. Diagnostics and Screening By Value
      2. Oncology Screening
        
        Oncology Screening By Value
      3. Companion Diagnostics
        
        Companion Diagnostics By Value
      4. Other Diagnostics
        
        Other Diagnostics By Value
    3. Research Studies
      1. Research Studies By Value
  7. Clinical Investigation
    1. By Value
    2. Infectious Diseases
      1. Infectious Diseases By Value
    3. Inherited Diseases
      1. Inherited Diseases By Value
    4. Idiopathic Diseases
      1. Idiopathic Diseases By Value
    5. Non-Communicable/Other Diseases
      1. Non-Communicable/Other Diseases By Value
  8. Reproductive Health
    1. By Value
    2. NIPT
      1. NIPT By Value
      2. Aneuploidy
        
        Aneuploidy By Value
      3. Microdeletions
        
        Microdeletions By Value
    3. PGT
      1. PGT By Value
    4. Newborn Genetic Screening
      1. Newborn Genetic Screening By Value
    5. Single Gene Analysis
      1. Single Gene Analysis By Value
  9. HLA Typing/Immune System Monitoring
    1. By Value
  10. Metagenomics, Epidemiology & Drug Development
    1. By Value
  11. Agrigenomics & Forensics
    1. By Value
  12. Consumer Genomics
    1. By Value
5. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Sequencing by Ligation
    1. By Value
  5. Pyrosequencing
    1. By Value
  6. Single Molecule Real Time Sequencing
    1. By Value
  7. Other Technologies
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type of Sequencing
1. Introduction
  1. Type of Sequencing By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing & Resequencing
  1. By Value
  2. DNA-based
    1. DNA-based By Value
  3. RNA-based
    1. RNA-based By Value
4. Whole Exome Sequencing
  1. By Value
5. RNA Sequencing
  1. By Value
6. CHIP Sequencing
  1. By Value
7. De Novo Sequencing
  1. By Value
8. Methyl Sequencing
  1. By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Services
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinical Laboratories
  1. By Value
3. Academics and Research Institutions
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Drug Discovery and Personalized Medicine
  1. By Value
3. Genetic Screening
  1. By Value
4. Agriculture and Animal Research
  1. By Value
5. Biomarkers and cancer
  1. By Value
6. Oncology
  1. By Value
  2. Diagnostics and Screening
    1. Diagnostics and Screening By Value
    2. Oncology Screening
      1. Oncology Screening By Value
    3. Companion Diagnostics
      1. Companion Diagnostics By Value
    4. Other Diagnostics
      1. Other Diagnostics By Value
  3. Research Studies
    1. Research Studies By Value
7. Clinical Investigation
  1. By Value
  2. Infectious Diseases
    1. Infectious Diseases By Value
  3. Inherited Diseases
    1. Inherited Diseases By Value
  4. Idiopathic Diseases
    1. Idiopathic Diseases By Value
  5. Non-Communicable/Other Diseases
    1. Non-Communicable/Other Diseases By Value
8. Reproductive Health
  1. By Value
  2. NIPT
    1. NIPT By Value
    2. Aneuploidy
      1. Aneuploidy By Value
    3. Microdeletions
      1. Microdeletions By Value
  3. PGT
    1. PGT By Value
  4. Newborn Genetic Screening
    1. Newborn Genetic Screening By Value
  5. Single Gene Analysis
    1. Single Gene Analysis By Value
9. HLA Typing/Immune System Monitoring
  1. By Value
10. Metagenomics, Epidemiology & Drug Development
  1. By Value
11. Agrigenomics & Forensics
  1. By Value
12. Consumer Genomics
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Sequencing by Ligation
  1. By Value
5. Pyrosequencing
  1. By Value
6. Single Molecule Real Time Sequencing
  1. By Value
7. Other Technologies
  1. By Value
UAE
1. By Type of Sequencing
  1. Introduction
    1. Type of Sequencing By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing & Resequencing
    1. By Value
    2. DNA-based
      1. DNA-based By Value
    3. RNA-based
      1. RNA-based By Value
  4. Whole Exome Sequencing
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. CHIP Sequencing
    1. By Value
  7. De Novo Sequencing
    1. By Value
  8. Methyl Sequencing
    1. By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Services
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinical Laboratories
    1. By Value
  3. Academics and Research Institutions
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Drug Discovery and Personalized Medicine
    1. By Value
  3. Genetic Screening
    1. By Value
  4. Agriculture and Animal Research
    1. By Value
  5. Biomarkers and cancer
    1. By Value
  6. Oncology
    1. By Value
    2. Diagnostics and Screening
      1. Diagnostics and Screening By Value
      2. Oncology Screening
        
        Oncology Screening By Value
      3. Companion Diagnostics
        
        Companion Diagnostics By Value
      4. Other Diagnostics
        
        Other Diagnostics By Value
    3. Research Studies
      1. Research Studies By Value
  7. Clinical Investigation
    1. By Value
    2. Infectious Diseases
      1. Infectious Diseases By Value
    3. Inherited Diseases
      1. Inherited Diseases By Value
    4. Idiopathic Diseases
      1. Idiopathic Diseases By Value
    5. Non-Communicable/Other Diseases
      1. Non-Communicable/Other Diseases By Value
  8. Reproductive Health
    1. By Value
    2. NIPT
      1. NIPT By Value
      2. Aneuploidy
        
        Aneuploidy By Value
      3. Microdeletions
        
        Microdeletions By Value
    3. PGT
      1. PGT By Value
    4. Newborn Genetic Screening
      1. Newborn Genetic Screening By Value
    5. Single Gene Analysis
      1. Single Gene Analysis By Value
  9. HLA Typing/Immune System Monitoring
    1. By Value
  10. Metagenomics, Epidemiology & Drug Development
    1. By Value
  11. Agrigenomics & Forensics
    1. By Value
  12. Consumer Genomics
    1. By Value
5. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Sequencing by Ligation
    1. By Value
  5. Pyrosequencing
    1. By Value
  6. Single Molecule Real Time Sequencing
    1. By Value
  7. Other Technologies
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type of Sequencing
1. Introduction
  1. Type of Sequencing By Value
2. Whole Genome Sequencing
  1. By Value
3. Targeted Sequencing & Resequencing
  1. By Value
  2. DNA-based
    1. DNA-based By Value
  3. RNA-based
    1. RNA-based By Value
4. Whole Exome Sequencing
  1. By Value
5. RNA Sequencing
  1. By Value
6. CHIP Sequencing
  1. By Value
7. De Novo Sequencing
  1. By Value
8. Methyl Sequencing
  1. By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Services
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinical Laboratories
  1. By Value
3. Academics and Research Institutions
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Drug Discovery and Personalized Medicine
  1. By Value
3. Genetic Screening
  1. By Value
4. Agriculture and Animal Research
  1. By Value
5. Biomarkers and cancer
  1. By Value
6. Oncology
  1. By Value
  2. Diagnostics and Screening
    1. Diagnostics and Screening By Value
    2. Oncology Screening
      1. Oncology Screening By Value
    3. Companion Diagnostics
      1. Companion Diagnostics By Value
    4. Other Diagnostics
      1. Other Diagnostics By Value
  3. Research Studies
    1. Research Studies By Value
7. Clinical Investigation
  1. By Value
  2. Infectious Diseases
    1. Infectious Diseases By Value
  3. Inherited Diseases
    1. Inherited Diseases By Value
  4. Idiopathic Diseases
    1. Idiopathic Diseases By Value
  5. Non-Communicable/Other Diseases
    1. Non-Communicable/Other Diseases By Value
8. Reproductive Health
  1. By Value
  2. NIPT
    1. NIPT By Value
    2. Aneuploidy
      1. Aneuploidy By Value
    3. Microdeletions
      1. Microdeletions By Value
  3. PGT
    1. PGT By Value
  4. Newborn Genetic Screening
    1. Newborn Genetic Screening By Value
  5. Single Gene Analysis
    1. Single Gene Analysis By Value
9. HLA Typing/Immune System Monitoring
  1. By Value
10. Metagenomics, Epidemiology & Drug Development
  1. By Value
11. Agrigenomics & Forensics
  1. By Value
12. Consumer Genomics
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Sequencing by Ligation
  1. By Value
5. Pyrosequencing
  1. By Value
6. Single Molecule Real Time Sequencing
  1. By Value
7. Other Technologies
  1. By Value
Brazil
1. By Type of Sequencing
  1. Introduction
    1. Type of Sequencing By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Targeted Sequencing & Resequencing
    1. By Value
    2. DNA-based
      1. DNA-based By Value
    3. RNA-based
      1. RNA-based By Value
  4. Whole Exome Sequencing
    1. By Value
  5. RNA Sequencing
    1. By Value
  6. CHIP Sequencing
    1. By Value
  7. De Novo Sequencing
    1. By Value
  8. Methyl Sequencing
    1. By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Services
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinical Laboratories
    1. By Value
  3. Academics and Research Institutions
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Drug Discovery and Personalized Medicine
    1. By Value
  3. Genetic Screening
    1. By Value
  4. Agriculture and Animal Research
    1. By Value
  5. Biomarkers and cancer
    1. By Value
  6. Oncology
    1. By Value
    2. Diagnostics and Screening
      1. Diagnostics and Screening By Value
      2. Oncology Screening
        
        Oncology Screening By Value
      3. Companion Diagnostics
        
        Companion Diagnostics By Value
      4. Other Diagnostics
        
        Other Diagnostics By Value
    3. Research Studies
      1. Research Studies By Value
  7. Clinical Investigation
    1. By Value
    2. Infectious Diseases
      1. Infectious Diseases By Value
    3. Inherited Diseases
      1. Inherited Diseases By Value
    4. Idiopathic Diseases
      1. Idiopathic Diseases By Value
    5. Non-Communicable/Other Diseases
      1. Non-Communicable/Other Diseases By Value
  8. Reproductive Health
    1. By Value
    2. NIPT
      1. NIPT By Value
      2. Aneuploidy
        
        Aneuploidy By Value
      3. Microdeletions
        
        Microdeletions By Value
    3. PGT
      1. PGT By Value
    4. Newborn Genetic Screening
      1. Newborn Genetic Screening By Value
    5. Single Gene Analysis
      1. Single Gene Analysis By Value
  9. HLA Typing/Immune System Monitoring
    1. By Value
  10. Metagenomics, Epidemiology & Drug Development
    1. By Value
  11. Agrigenomics & Forensics
    1. By Value
  12. Consumer Genomics
    1. By Value
5. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Sequencing by Ligation
    1. By Value
  5. Pyrosequencing
    1. By Value
  6. Single Molecule Real Time Sequencing
    1. By Value
  7. Other Technologies
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Next Generation Sequencing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Agilent Technologies
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Bio-Rad Laboratories Inc.
DNASTAR Inc.
Eurofins Scientific
Hoffmann-La Roche Ltd
Illumina Inc.
Danaher Corporation (IDT)
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Qiagen
Thermo Fisher Scientific Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment